Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice Concerning Grant of Post-delivery Restricted Stock Units (RSUs)
Notice of Introduction of Executive Officer System and Changes in Directors of the Board
Notice Regarding Selection as a Constituent of the JPX Start-Up Acceleration 100 Index
Presentation material of financial results for the fiscal year ended December 31, 2025 (FY2025)
Non-consolidated Financial Results for the Fiscal Year Ended December 31, 2025
Heartseed, Net Income for The Current Fiscal Year, with a Change in the Fiscal Year-End, is loss of 2.1 Billion Yen
Notice Regarding the Revisions of Full-Year Financial Results Forecastfor the Fiscal Year Ending December 31, 2025
Non-consolidated Financial Results for the Twelve Months Ended October 31, 2025 (Under Japanese GAAP)
Heartseed, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 2.5 times
Completion of 30-day review for clinical trial notification for Phase I/II study of HS-005 (catheter administration)
Supplemental comments regarding termination of partnership with Novo Nordisk AS (#3)
Notice of submission of clinical trial notification for Phase I/II study of HS-005 targeting severe HF due to IHD and DCM
Supplemental comments regarding termination of partnership with Novo Nordisk AS (#2)
Supplemental comments regarding termination of partnership with Novo Nordisk AS
Notice regarding termination of partnership with Novo Nordisk AS
Heartseed, Nov-Jul (Cumulative 3Q) Ordinary Profit Turns to Profit
Notice regarding the new partner for delivery catheter system for allogeneic iPS cell-derived cardiomyocyte spheroids
Non-consolidated Financial Results for the Nine Months Ended July 31, 2025 (Under Japanese GAAP)
Notice Regarding the Revisions of Full-Year Financial Results Forecast for the Fiscal Year Ending December 31, 2025
Heartseed, Ordinary Profit Forecast for the Fiscal Year Turns to Profit, Exceeds Expectations